Provided by Tiger Trade Technology Pte. Ltd.

CytomX Therapeutics

3.36
+0.15004.67%
Post-market: 3.360.00000.00%19:41 EDT
Volume:2.38M
Turnover:7.87M
Market Cap:731.48M
PE:-7.39
High:3.38
Open:3.20
Low:3.17
Close:3.21
52wk High:8.21
52wk Low:1.90
Shares:217.70M
Float Shares:180.00M
Volume Ratio:0.84
T/O Rate:1.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4548
EPS(LYR):-0.1500
ROE:-37.75%
ROA:-19.58%
PB:2.42
PE(LYR):-22.40

Loading ...

Mar 01, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2022

Major Issues Report

8-K - Current report
Feb 01, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Major Issues Report

8-K - Current report
Jan 03, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 07, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Oct 07, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 04, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Correspondence

CORRESP [Cover] - Correspondence